Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
30 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
NATURAL PHARMA from Brussel, company number BE0737684505, closed financial year 2025 with a result of € 62,724 after tax. For that financial year NATURAL PHARMA recorded a gross margin of € 240,737 and equity of € 285,428. Compared with financial year 2024, the result moved from € 80,429 to € 62,724. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 285,428
▲ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 62,724
▼ 22% vs 2024
Profit after tax over the fiscal year.
€ 235,609
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 255,428.
People and assets in 2025
€ 103,773
▼ 24% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 25,758
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 141,860
▼ 20% vs 2024
€ 36,868 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 157,716
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 41,949
▼ 13% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 250,136 | € 274,437 | € 288,881 | € 240,737 | ▼ 17% |
| Profit after taxes | € 123,349 | € 106,227 | € 80,429 | € 62,724 | ▼ 22% |
| Equity | € 208,148 | € 267,275 | € 222,704 | € 285,428 | ▲ 28% |
| Total debts | € 426,681 | € 434,640 | € 402,437 | € 377,493 | ▼ 6% |
| Cash | € 246,266 | € 307,787 | € 212,661 | € 235,609 | ▲ 11% |
| Retained profit | € 178,148 | € 237,275 | € 192,704 | € 255,428 | ▲ 33% |
| Dividend | € 0 | € 47,100 | € 125,000 | € 0 | ▼ 100% |
| Bank debt | € 248,519 | € 213,612 | € 178,063 | € 141,860 | ▼ 20% |
| Balance sheet total | € 634,829 | € 701,916 | € 625,141 | € 662,921 | ▲ 6% |
Key figures of NATURAL PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NATURAL PHARMA?
What happened at NATURAL PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 62,724 (▼ 22% vs 2024). filed late Source: NBB ↗
- New establishment in Vilvoorde. KBO
- New establishment in Brussel. KBO
- Ibrahim El Kaddouri became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 123,349 profit in 2022 to € 62,724 profit in 2025.
Paid € 109,838 in corporate taxes since 2022.
Best year ever: 2022, with € 123,349 profit.
Paid out € 172,100 in dividends to the owners in total.
A new publication or filing at NATURAL PHARMA? We notify you, reason included.
Follow NATURAL PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind NATURAL PHARMA is Ibrahim El Kaddouri.
Directors
According to the 2025 annual accounts
Ibrahim El Kaddouri
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Oorlogskruisenlaan 94
1120 Brussel
Oorlogskruisenlaan 135
1120 Brussel
Active since 14 November 2019
Kareelerf 16
1800 Vilvoorde
Active since 28 February 2025
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 30 companies are registered at this address.
All companies at this address →ID TEAM
€ 75,792 gross margin · 2025
WINNER SOFTWARE
€ 126,229 revenue · 2024
NETFLY
€ 52,486 gross margin · 2025
BDMS GROUP
€ 121,566 gross margin · 2024
Cleaneau
€ 157,869 gross margin · 2024
+25 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
INFOMANIAK-AS, CH
Website info
Features
Security
Network
Details
- Company number
- 0737.684.505
- VAT number
- BE 0737.684.505
- Registered office
- Oorlogskruisenlaan 94, 1120 Brussel
- Names & denominations
- NATURAL PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 November 2019
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten